Results 141 to 150 of about 38,862 (155)

Pembrolizumab for Early Triple-Negative Breast Cancer

New England Journal of Medicine, 2020
Javier Cortes, Lajos Pusztai, Sherko Kümmel   +2 more
exaly  

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Nature Reviews Clinical Oncology, 2016
Eapm Working Group For Oncology Clinical Research, Melinda E Sanders, Luca Gianni   +2 more
exaly  

Triple-negative breast cancer: disease entity or title of convenience?

Nature Reviews Clinical Oncology, 2010
Lisa A Carey, Giuseppe Viale, David A Cameron   +2 more
exaly  

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies

Cancer Cell, 2019
Yi-Zhou Jiang, Chen Suo, Xin Hu
exaly  

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

Lancet, The, 2017
Carsten Denkert, Andrew N J Tutt
exaly  

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Cell, 2018
Charissa R Kim, Johan Hartman, Nicola Crosetto   +2 more
exaly  

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

New England Journal of Medicine, 2018
Hope S Rugo, Hiroji Iwata, Seock-Ah Im
exaly  

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

New England Journal of Medicine, 2020
Klaus F Rabe, Fernando J Martinez, Chen Wang   +2 more
exaly  

Triple-Negative Breast Cancer

New England Journal of Medicine, 2010
William D Foulkes, Jorge S Reis-Filho
exaly  

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy

Cell Metabolism, 2023
exaly